Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children
Scopus
Open Access Toplam 142 atıf DOI
Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or RNASEL in five unrelated children with MIS-C. The cytosolic double-stranded RNA (dsRNA)-sensing OAS1 and OAS2 generate 2'-5'-linked oligoadenylates (2-5A) that activate the single-stranded RNA-degrading ribonuclease L (RNase L). Monocytic cell lines and primary myeloid cells with OAS1, OAS2, or RNase L deficiencies produce excessive amounts of inflammatory cytokines upon dsRNA or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulation. Exogenous 2-5A suppresses cytokine production in OAS1-deficient but not RNase L-deficient cells. Cytokine production in RNase L-deficient cells is impaired by MDA5 or RIG-I deficiency and abolished by mitochondrial antiviral-signaling protein (MAVS) deficiency. Recessive OAS-RNase L deficiencies in these patients unleash the production of SARS-CoV-2-triggered, MAVS-mediated inflammatory cytokines by mononuclear phagocytes, thereby underlying MIS-C.
Atıf Kaynağı
Atıf Yapan Yayın
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
Scopus
Havuzumuzda Open Access 12 atıf almış
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, “burdenMC,” which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5-5.3, P < 10-6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.
Atıf Yapan Makale Bilgileri
Kurumlar (55)
Aix Marseille Université
Marseille, France
Ankara City Hospital
Ankara, Turkey
Ankara Yildirim Beyazit University
Ankara, Turkey
Bilkent Üniversitesi
Ankara, Turkey
Bristol Myers Squibb
Princeton, United States
Charles University
Prague, Czech Republic
CHU de Lyon
Lyon, France
CHU Sainte-Justine - Le Centre Hospitalier Universitaire Mère-Enfant
Montreal, Canada
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital
Ankara, Turkey
Emma Kinderziekenhuis
Amsterdam, Netherlands